Jia Jie Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 11, 2021
Share
Jia Jie Biomedical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 55.51 million compared to TWD 54.35 million a year ago. Net income was TWD 0.521 million compared to TWD 5.07 million a year ago. Basic earnings per share from continuing operations was TWD 0.01 compared to TWD 0.07 a year ago. Diluted earnings per share from continuing operations was TWD 0.01 compared to TWD 0.07 a year ago.
For the nine months, sales was TWD 160.72 million compared to TWD 192.78 million a year ago. Net loss was TWD 2.9 million compared to TWD 22 million a year ago. Basic loss per share from continuing operations was TWD 0.03 compared to TWD 0.32 a year ago. Diluted loss per share from continuing operations was TWD 0.03 compared to TWD 0.32 a year ago.
Jia Jie Biomedical Co Ltd is a Taiwan-based company mainly engaged in the processing, production and distribution of turtles and turtle processed products. The Company operates through two business segments. Taiwan Operation segment is engaged in the production and sale of health foods. China Mainland Operation segment is engaged in the production of water purification equipment and related parts. Products are include nutrition and health care series, health water series, home supplies series. Products are mainly sold to Taiwan and mainland China.
JIA JIE BIOMEDICAL CO., LTD. 
